Swiss Re (SREN) Given a CHF 95 Price Target by Commerzbank Analysts
Swiss Re (VTX:SREN) has been given a CHF 95 price target by equities research analysts at Commerzbank in a research report issued on Thursday. The brokerage currently has a “sell” rating on the stock. Commerzbank’s price objective indicates a potential upside of 4.45% from the stock’s current price.
Several other analysts also recently commented on the stock. Goldman Sachs Group set a CHF 99 target price on shares of Swiss Re and gave the stock a “buy” rating in a report on Monday, September 11th. Deutsche Bank set a CHF 104 target price on shares of Swiss Re and gave the stock a “buy” rating in a report on Monday, August 28th. BNP Paribas set a CHF 77 target price on shares of Swiss Re and gave the stock a “sell” rating in a report on Monday, August 28th. UBS set a CHF 79 target price on shares of Swiss Re and gave the stock a “sell” rating in a report on Tuesday, October 10th. Finally, Jefferies Group set a CHF 91 target price on shares of Swiss Re and gave the stock a “neutral” rating in a report on Thursday, August 31st. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the company’s stock. Swiss Re currently has an average rating of “Hold” and a consensus target price of CHF 95.21.
Swiss Re (SREN) opened at CHF 90.95 on Thursday. Swiss Re has a 52 week low of CHF 81.65 and a 52 week high of CHF 98.50.
Swiss Re Company Profile
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re AG and related companies with MarketBeat.com's FREE daily email newsletter.